Medical device for Oral Mucositis(OM) and Dry Mouth(DM)

Mucosamin® is a CE marked medical device and is an oral liquid formulation that helps prevent and treat oral mucositis caused by chemotherapy or radiation therapy. Hyaluronic acid, the main ingredient of mucosamin, prevents cell damage through antioxidant activity and helps wound healing by physically forming a protective film. In addition, the patented cluster of amino acids (Glycine, L-Proline, L-Leucine, L-Lysine), collagen precursor restores mucosal ulcers and protects fibroblasts. Mucosamin® is a competitive medical device that can also expand to the dry mouth market with hydration effect.



Medical device for Oral Mucositis (OM) and Dry Mouth (DM)


Mucosamin® is a CE marked medical device and is an oral liquid formulation that helps prevent and treat oral mucositis caused by chemotherapy or radiation therapy. Hyaluronic acid, the main ingredient of mucosamin, prevents cell damage through antioxidant activity and helps wound healing by physically forming a protective film. In addition, the patented cluster of amino acids (Glycine, L-Proline, L-Leucine, L-Lysine), collagen precursor restores mucosal ulcers and protects fibroblasts. Mucosamin® is a competitive medical device that can also expand to the dry mouth market with hydration effect.



Approved

Bangladesh, Canada, EU, Israel, Iran, Jordan, Nepal, Switzerland, Morocco, Turkey, Tunisia, UAE, UK, Vietnam


Registration in process

Australia, Egypt, New Zealand, KSA


Territory Secured in APAC

Hong Kong, Indonesia, Japan, Malaysia, Macau, Philippines, Singapore, Taiwan, Thailand, Vietnam 



Approved Countries and Territory Secured

for Brand Expansion in Asia


Development Timeline

*South East Asia

Copyright 2021 - BIXINK   │   Terms of Use

 Contact   │   Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, 

Republic of Korea

Copyright 2021 - BIXINK │ Terms of Use │ Contact  │  Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, Republic of Korea